AzTrials
AzTrials

Nasal IntubationNCT03126344

Nasal Intubation Using King Vision Video Laryngoscopy

A study testing King Vision video laryngoscope, McGrath MAC video laryngoscope and Macintosh laryngoscope in people with Nasal Intubation, run by Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study was designed to determine the comparison between the King Vision video laryngoscope 、 McGrath MAC video laryngoscope and Macintosh laryngoscope for nasotracheal intubation.Patients were divided into 3 groups of 30 patients each.Patients of King Vision group [n=30]、 McGrath MAC group [n=30] and Macintosh… Read more about this study

Who is it for?
Ages 18 to 55 yearsHealthy volunteers can take part
Conditions the study is for
Nasal Intubation
What is being tested?
King Vision video laryngoscope, McGrath MAC video laryngoscope and Macintosh laryngoscope
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
99 participants
Where
1 siteChina
Study dates
1 Jun 2017to 5 Jan 2018
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • ASA physical status 1-2
  • general anesthesia with nasotracheal intubation
  • anticipated difficult airway

Who cannot join

  • contraindications to nasal intubation
  • Patients with a history of anti-hypertensive drugs

Trial locations and contacts

1 site in 1 country.

China1 site
  • Shanghai Ninth People's Hospital,Affililated to Shanghai Jiaotong University School of Medicine

    Shanghai, Shanghai Municipality, 200011

Other trials in China

About this study

Official title: Comparison King Vision Video Laryngoscopy 、McGrath MAC Video Laryngoscopy With Macintosh Laryngoscopy for Nasal Intubation

This study was designed to determine the comparison between the King Vision video laryngoscope 、 McGrath MAC video laryngoscope and Macintosh laryngoscope for nasotracheal intubation.Patients were divided into 3 groups of 30 patients each.Patients of King Vision group [n=30]、 McGrath MAC group [n=30] and Macintosh group[n=30]were intubated using respective devices.This study is the first to search the use of King Vision video laryngoscope for nasotracheal intubation.

Being tested
King Vision video laryngoscope, McGrath MAC video laryngoscope, Macintosh laryngoscope
Keywords
King Vision

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • King Vision video laryngoscopeDevice

    nasal intubation using King Vision video laryngoscope Device after general anesthesia induction

  • McGrath MAC video laryngoscopeDevice

    nasal intubation using McGrath MAC video laryngoscope Device after general anesthesia induction

  • Macintosh laryngoscopeDevice

    nasal intubation using Macintosh laryngoscope Device after general anesthesia induction

Study groups in NCT03126344
Study groupRoleWhat they receive
King Vision video laryngoscopeExperimentalNot described
Receives: Device: King Vision video laryngoscope
McGrath MAC video laryngoscopeExperimentalNot described
Receives: Device: McGrath MAC video laryngoscope
MacintoshActive comparatorNot described
Receives: Device: Macintosh laryngoscope

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to Intubation

    the interval between opening the mouth and the time when three consecutive end-tidal CO2 waves were appeared on the monitor

    Measured: 0 min after nasal intubation

Secondary outcomes (2)
  1. Laryngoscopy Time

    time to expose the glottis

    Measured: after expose the glottis

  2. Number of Participants With Complications

    sore throat, hoarseness, etc

    Measured: 24h after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Apr 2017
  2. Study start1 Jun 2017
  3. Primary completion1 Jan 2018
  4. Study completion5 Jan 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
99 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03126344
Sponsor's protocol ID
suny2
Status last verified
Sep 2020
First submitted
19 Apr 2017
Last updated
14 Sep 2020
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes

Publications

  • Zhu H, Liu J, Suo L, Zhou C, Sun Y, Jiang H. A randomized controlled comparison of non-channeled king vision, McGrath MAC video laryngoscope and Macintosh direct laryngoscope for nasotracheal intubation in patients with predicted difficult intubations. BMC Anesthesiol. 2019 Aug 31;19(1):166. doi: 10.1186/s12871-019-0838-z.

    PubMed 31470814

Questions about this trial

What is this clinical trial studying?

A study testing King Vision video laryngoscope, McGrath MAC video laryngoscope and Macintosh laryngoscope in people with Nasal Intubation, run by Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 14 Sep 2020). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to Intubation (time frame: 0 min after nasal intubation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03126344, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Sep 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in